跳至主要内容
临床试验/CTRI/2018/02/012255
CTRI/2018/02/012255已完成1 期

Open label clinical trial to study the efficacy of Nimbadi Kalka in Diabetic Foot Ulcer.

Amrita School of Ayurveda0 个研究点目标入组 15 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)HbA1c between 6-7 %
  • 2)Wound penetrating to tendons associated with signs of infection (Texas B2 Classification)
  • 3)Wound sites:- plantar surface of foot and toes (metatarsal heads and mid foot), dorsal interphalangeal joints

排除标准

  • 1)Age below 40 years and above 70 years
  • 2)HbA1c above 7
  • 3)More than B2 Texas classification
  • 4)Wound anywhere except dorsal and plantar region
  • 5)Patients with other systemic pathology (TB, HIV, HBsAg, VDRL, Malignancy)
  • 6)Patient on other medications like steroids

研究者

发起方
Amrita School of Ayurveda

相似试验